Close

Analyst Ratings for aTyr Pharma (LIFE) [Sells]

LIFE Rating Summary

LIFE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on LIFE
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $18.00 (+818.4%) * Over Last 12-Mos
Rating Score: 5.5 / 10   Percentile Rank: 59%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/14/2018 JPMorgan N/A Downgrade Underweight
(Neutral)
N/A
(N/A)
3.40
(1.96)
-42.35% Details
Like LIFE Ratings? Also take a look at XBIO

LIFE Ratings News